Full weight-based cytotoxic chemotherapy doses are recommended to treat obese adults with cancer -- an @ASCO guideline update https://t.co/0E9avJR8zn #JCO
Full weight-based cytotoxic chemotherapy doses are recommended to treat obese adults with cancer -- an @ASCO guideline update https://t.co/0E9avJR8zn #JCO
Cuando le dije a mi abuela que iba a ser hematóloga, la pobre no tenía ni idea de lo que era eso...aquí un pequeño resumen contado por los que mejor saben lo que hacemos. @sehh_es
https://t.co/Nk2Gs8Q54V
T-cell-mediated aGvHD development: the roles that specific epigenetic regulators play and how their modulation could disrupt that process with beneficial effects.
https://t.co/CLDyJoeLMD
Alectinib (2nd gen Alk inhibitor) in relapsed refractory Alk+ DLBCL
• Fukano et al
• 10 pts, median age 19
• 8/10 responded
• 1y PFS 58.3%
• med duration therapy 340d
Clearly active - will it be available for the rare patients who would benefit?
https://t.co/cqJfBkLhSo
Variants mononuclear variant, RS cells with multilobulated nuclei with small nucleoli and lymphocyte predominant or popcorn cells en NLPHL with lobulated, vesicular nuclei with multiple small nucleoli that are located peripherally
Splenic diffuse red pulp lymphoma is another provisional entity similar to HCL with 60% of medium sized villous lymphoid cells in the peripheral blood express CD11c inconsistent CD103 and rarely CD123 or CD25
Hairy cell leukemia variant represent 10% of HCL cases abnormal lymphoid cells have a morphology that is intermediate between prolymphocytes and hairy cells. The inmunological score is low 0-1 no CD25 or CD200
Paroxysmal nocturnal hemoglobinuria is a rare, clonal HSC disorder that manifest with a chronic intravascular hemolytic anemia mediated by alternative pathway of complement